Wally R. Smith

10.6k total citations · 2 hit papers
165 papers, 6.3k citations indexed

About

Wally R. Smith is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Wally R. Smith has authored 165 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Genetics, 68 papers in Hematology and 42 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Wally R. Smith's work include Hemoglobinopathies and Related Disorders (102 papers), Iron Metabolism and Disorders (62 papers) and Pharmacological Effects and Toxicity Studies (29 papers). Wally R. Smith is often cited by papers focused on Hemoglobinopathies and Related Disorders (102 papers), Iron Metabolism and Disorders (62 papers) and Pharmacological Effects and Toxicity Studies (29 papers). Wally R. Smith collaborates with scholars based in United States, Brazil and United Kingdom. Wally R. Smith's co-authors include Donna K. McClish, James L. Levenson, Viktor E. Bovbjerg, Susan D. Roseff, Imoigele P. Aisiku, John D. Roberts, Lynne Penberthy, Kenneth I. Ataga, Abdullah Kutlar and Lakshmanan Krishnamurti and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wally R. Smith

151 papers receiving 6.1k citations

Hit Papers

Sickle cell disease 2016 2026 2019 2022 2018 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wally R. Smith United States 39 4.2k 3.0k 1.7k 666 612 165 6.3k
Sophie Lanzkron United States 42 5.0k 1.2× 3.7k 1.2× 1.9k 1.1× 579 0.9× 382 0.6× 212 6.5k
Jane S. Hankins United States 36 3.1k 0.7× 2.4k 0.8× 1.3k 0.8× 336 0.5× 292 0.5× 257 4.4k
Kwaku Ohene‐Frempong United States 46 7.1k 1.7× 5.9k 2.0× 2.2k 1.2× 208 0.3× 600 1.0× 140 8.7k
Carlton Haywood United States 35 2.6k 0.6× 1.7k 0.6× 987 0.6× 566 0.8× 152 0.2× 82 3.6k
Kaleb Michaud United States 62 1.3k 0.3× 3.0k 1.0× 211 0.1× 654 1.0× 638 1.0× 266 13.7k
Merete Lund Hetland Denmark 51 847 0.2× 2.0k 0.7× 137 0.1× 389 0.6× 670 1.1× 347 8.9k
Montserrat Rué Spain 38 562 0.1× 727 0.2× 393 0.2× 465 0.7× 1.3k 2.1× 146 6.4k
Patrick Lefèbvre United States 43 381 0.1× 714 0.2× 529 0.3× 204 0.3× 310 0.5× 469 7.3k
Sven Trelle Switzerland 35 525 0.1× 519 0.2× 254 0.1× 472 0.7× 285 0.5× 95 7.2k
M.A.F. El‐Hazmi Saudi Arabia 25 1.1k 0.3× 849 0.3× 482 0.3× 148 0.2× 219 0.4× 133 2.7k

Countries citing papers authored by Wally R. Smith

Since Specialization
Citations

This map shows the geographic impact of Wally R. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wally R. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wally R. Smith more than expected).

Fields of papers citing papers by Wally R. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wally R. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wally R. Smith. The network helps show where Wally R. Smith may publish in the future.

Co-authorship network of co-authors of Wally R. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Wally R. Smith. A scholar is included among the top collaborators of Wally R. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wally R. Smith. Wally R. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valrie, Cecelia, et al.. (2024). Investigating home‐based opioid use among youth with sickle cell disease using ecological momentary assessment. Pediatric Blood & Cancer. 71(8). e31116–e31116. 1 indexed citations
2.
Smith, Wally R., et al.. (2024). Dysphagia in patients with sickle cell disease: An understudied problem. Journal of the National Medical Association. 116(2). 126–130. 1 indexed citations
4.
Sturgeon, John A., et al.. (2023). Race, Ethnicity, and Belief in a Just World: Implications for Chronic Pain Acceptance Among Individuals with Chronic Low Back Pain. Journal of Pain. 24(12). 2309–2318. 3 indexed citations
5.
Brown, R. Clark, Modupe Idowu, Richard A. Drachtman, et al.. (2023). Patient‐Reported Experiences in Voxelotor‐Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study. BioMed Research International. 2023(1). 7533111–7533111. 6 indexed citations
7.
Sisler, India, et al.. (2023). Intraindividual pain variability metrics for youth with sickle cell disease: Relations to health outcomes. Pediatric Blood & Cancer. 70(4). e30194–e30194. 2 indexed citations
8.
Callaghan, Michael U., et al.. (2022). Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease. SHILAP Revista de lepidopterología. 3(3). 653–659. 4 indexed citations
9.
Shah, Nirmish, David O. Beenhouwer, Michael S. Broder, et al.. (2020). <p>Development of a Severity Classification System for Sickle Cell Disease</p>. ClinicoEconomics and Outcomes Research. Volume 12. 625–633. 19 indexed citations
10.
Tong, Sebastian T., et al.. (2019). Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments. The Journal of the American Board of Family Medicine. 32(2). 272–278. 3 indexed citations
11.
Smith, Wally R., et al.. (2017). Reducing Hospital Use of Urban Sickle Cell Adults Using Multidisciplinary Adult Care and Instrumental Support. Blood. 130. 5661. 1 indexed citations
12.
Gibbons, Michael, et al.. (2016). Top 10 Things You Need to Know to Run Community Health Worker Programs: Lessons Learned in the Field. Southern Medical Journal. 109(9). 579–582. 4 indexed citations
13.
Carden, Marcus A., et al.. (2016). Health literacy and disease-specific knowledge of caregivers for children with sickle cell disease. Pediatric Hematology and Oncology. 33(2). 121–133. 20 indexed citations
14.
Telen, Marilyn J., Ted Wun, Timothy L. McCavit, et al.. (2015). Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use. Blood. 125(17). 2656–2664. 163 indexed citations
15.
Treadwell, Marsha, Shirley Johnson, India Sisler, et al.. (2015). Development of a sickle cell disease readiness for transition assessment. International Journal of Adolescent Medicine and Health. 28(2). 193–201. 26 indexed citations
16.
Treadwell, Marsha, Shirley Johnson, India Sisler, et al.. (2015). Self-efficacy and readiness for transition from pediatric to adult care in sickle cell disease. International Journal of Adolescent Medicine and Health. 28(4). 381–388. 32 indexed citations
17.
Derlega, Valerian J., et al.. (2014). How Patients' Self-Disclosure about Sickle Cell Pain Episodes to Significant Others Relates to Living with Sickle Cell Disease. Pain Medicine. 15(9). 1496–1507. 14 indexed citations
18.
Bearman, Gonzalo, Alexandre R. Marra, Curtis N. Sessler, et al.. (2007). A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. American Journal of Infection Control. 35(10). 650–655. 61 indexed citations
19.
Smith, Wally R., J. James Cotter, & Louis F. Rossiter. (1996). System change: quality assessment and improvement for Medicaid managed care.. PubMed. 17(4). 97–115. 7 indexed citations
20.
Smith, Wally R., et al.. (1989). Hypermedia or Hyperchaos: Using HyperCard to Teach Medical Decision Making.. PubMed Central. 858–863. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026